Table 2 Pleural, pericardial or peritoneal cavity effusions suspected to be related to MPTK-CAR-T cell infusion

From: Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

Type of event

≤4 Wk After infusion (N = 15)

>4 Wk After infusion (N = 15)

Grade < 3

Grade ≥ 3

Grade < 3

Grade ≥ 3

Number of patients (Percent)

Pleural effusion

3 (20.0)

1 (6.7)

2 (13.3)

Pericardial effusion

1 (6.7)

1 (6.7)

1 (6.7)

Ascites

1 (6.7)

2 (13.3)